Xience Skypoint

Abbott's newest everolimus-eluting coronary stent, built on the Xience cobalt-chromium platform with an enhanced strut design for improved expansion and deliverability; indicated for de novo native coronary lesions up to 44mm and vessels 2.25-5.25mm, including chronic total occlusions.

Indicated lesion length

up to 44mm

Vessel size

2.25-5.25mm